Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Cash Flow from Operating Activities

    Back to Cashflow Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Operating Activities ₹37 Cr₹36 Cr₹31 Cr₹23 Cr₹30 Cr

What is the latest Cash Flow from Operating Activities ratio of BETA DRUGS ?

The latest Cash Flow from Operating Activities ratio of BETA DRUGS is ₹37 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Operating Activities
Mar2026₹37 Cr
Mar2025₹36 Cr
Mar2024₹31 Cr
Mar2023₹23 Cr
Mar2022₹30 Cr

How is Cash Flow from Operating Activities of BETA DRUGS Trending?

Years Cash Flow from Operating Activities % Change
Mar2026 ₹37 Cr
3.16
Mar2025 ₹36 Cr
16.86
Mar2024 ₹31 Cr
32.28
Mar2023 ₹23 Cr
-21.08
Mar2022 ₹30 Cr -

Compare Cash Flow from Operating Activities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹1,958.3 Cr -2.9% 6% 8.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-2.9%

6%

8.2%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses